David L. Huso

21.6k total citations · 6 hit papers
155 papers, 15.3k citations indexed

About

David L. Huso is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, David L. Huso has authored 155 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 41 papers in Genetics and 39 papers in Oncology. Recurrent topics in David L. Huso's work include Cancer Cells and Metastasis (16 papers), Connective tissue disorders research (14 papers) and Acute Myeloid Leukemia Research (11 papers). David L. Huso is often cited by papers focused on Cancer Cells and Metastasis (16 papers), Connective tissue disorders research (14 papers) and Acute Myeloid Leukemia Research (11 papers). David L. Huso collaborates with scholars based in United States, United Kingdom and Canada. David L. Huso's co-authors include Cynthia L. Sears, Shaoguang Wu, Bert Vogelstein, Kenneth W. Kinzler, Baktiar Karim, Franck Housseau, Xinqun Wu, Harry C. Dietz, Drew M. Pardoll and Shervin Rabizadeh and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

David L. Huso

154 papers receiving 15.1k citations

Hit Papers

A human colonic commensal promotes colon tumorigenesis... 1999 2026 2008 2017 2009 2006 2018 2005 1999 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Huso United States 64 7.9k 4.0k 2.8k 2.6k 2.2k 155 15.3k
Neil R. Hackett United States 56 7.9k 1.0× 3.1k 0.8× 2.6k 0.9× 1.4k 0.5× 1.8k 0.8× 159 13.2k
Ramesh A. Shivdasani United States 76 9.8k 1.2× 2.5k 0.6× 3.6k 1.3× 1.8k 0.7× 1.8k 0.8× 180 17.3k
John F. Engelhardt United States 79 11.1k 1.4× 7.4k 1.9× 1.5k 0.5× 5.2k 2.0× 1.0k 0.5× 315 21.6k
Jesús Prìeto Spain 82 8.7k 1.1× 3.6k 0.9× 6.0k 2.1× 1.1k 0.4× 1.7k 0.8× 606 24.6k
James R. Goldenring United States 76 8.5k 1.1× 2.0k 0.5× 2.7k 1.0× 2.1k 0.8× 1.1k 0.5× 332 17.2k
Austin Gurney United States 57 8.9k 1.1× 1.5k 0.4× 5.4k 1.9× 1.1k 0.4× 2.9k 1.3× 98 19.9k
Arie Abo United States 41 8.7k 1.1× 2.0k 0.5× 4.3k 1.5× 757 0.3× 1.1k 0.5× 56 15.1k
Agnès Viale United States 64 12.1k 1.5× 1.8k 0.4× 5.4k 1.9× 2.9k 1.1× 3.9k 1.7× 139 20.7k
Juan Iovanna France 69 8.7k 1.1× 1.5k 0.4× 5.6k 2.0× 1.2k 0.5× 3.0k 1.3× 403 16.4k
Milton J. Finegold United States 90 15.4k 2.0× 7.2k 1.8× 6.4k 2.3× 3.0k 1.1× 2.6k 1.2× 386 33.5k

Countries citing papers authored by David L. Huso

Since Specialization
Citations

This map shows the geographic impact of David L. Huso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Huso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Huso more than expected).

Fields of papers citing papers by David L. Huso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Huso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Huso. The network helps show where David L. Huso may publish in the future.

Co-authorship network of co-authors of David L. Huso

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Huso. A scholar is included among the top collaborators of David L. Huso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Huso. David L. Huso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Habashi, Jennifer, Elena Gallo MacFarlane, Rustam Bagirzadeh, et al.. (2019). Oxytocin antagonism prevents pregnancy-associated aortic dissection in a mouse model of Marfan syndrome. Science Translational Medicine. 11(490). 38 indexed citations
2.
Dejea, Christine M., Payam Fathi, John M. Craig, et al.. (2018). Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 359(6375). 592–597. 782 indexed citations breakdown →
3.
Merino, Vanessa F., Nguyen Nguyen, Kideok Jin, et al.. (2016). Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer. Cancer Research. 76(7). 2013–2024. 37 indexed citations
4.
Housseau, Franck, Shaoguang Wu, Elizabeth C. Wick, et al.. (2016). Redundant Innate and Adaptive Sources of IL17 Production Drive Colon Tumorigenesis. Cancer Research. 76(8). 2115–2124. 102 indexed citations
5.
Shields, Christina E. DeStefano, Sara W. Van Meerbeke, Franck Housseau, et al.. (2016). Reduction of Murine Colon Tumorigenesis Driven by Enterotoxigenic Bacteroides fragilis Using Cefoxitin Treatment. PMC. 3 indexed citations
6.
Bai, Ren-Yuan, et al.. (2016). Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model. Oncotarget. 7(42). 68571–68584. 62 indexed citations
7.
Geis, Abby L., Hongni Fan, Xinqun Wu, et al.. (2015). Regulatory T-cell Response to Enterotoxigenic Bacteroides fragilis Colonization Triggers IL17-Dependent Colon Carcinogenesis. Cancer Discovery. 5(10). 1098–1109. 142 indexed citations
8.
Han, Liangfeng, Adam Diehl, Nguyen K. Nguyen, et al.. (2014). The Notch Pathway Inhibits TGFβ Signaling in Breast Cancer through HEYL-Mediated Crosstalk. Cancer Research. 74(22). 6509–6518. 27 indexed citations
9.
Chen, S-H, W‐C Hung, C. Paul, et al.. (2014). Fluid shear promotes chondrosarcoma cell invasion by activating matrix metalloproteinase 12 via IGF-2 and VEGF signaling pathways. Oncogene. 34(35). 4558–4569. 48 indexed citations
10.
Reynolds, Taylor L., et al.. (2013). 53BP1 Is Limiting for NHEJ Repair in ATM-deficient Model Systems That Are Subjected to Oncogenic Stress or Radiation. Molecular Cancer Research. 11(10). 1223–1234. 13 indexed citations
11.
Ericson, Kajsa, Christine Gan, Ian Cheong, et al.. (2010). Genetic inactivation of AKT1 , AKT2 , and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation. Proceedings of the National Academy of Sciences. 107(6). 2598–2603. 106 indexed citations
12.
Andrés‐Mateos, Eva, Rebeca Mejı́as, Masayuki Sasaki, et al.. (2009). Unexpected Lack of Hypersensitivity in LRRK2 Knock-Out Mice to MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine). Journal of Neuroscience. 29(50). 15846–15850. 95 indexed citations
13.
Song, Hong, Robert F. Hobbs, Ravy K. Vajravelu, et al.. (2009). Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y. Cancer Research. 69(23). 8941–8948. 118 indexed citations
14.
Cello, Francescopaolo Di, Jöelle Hillion, Jeanne Kowalski, et al.. (2008). Cyclooxygenase inhibitors block uterine tumorigenesis in HMGA1a transgenic mice and human xenografts. Molecular Cancer Therapeutics. 7(7). 2090–2095. 26 indexed citations
15.
Tesfaye, Abeba, Francescopaolo Di Cello, Jöelle Hillion, et al.. (2007). The High-Mobility Group A1 Gene Up-Regulates Cyclooxygenase 2 Expression in Uterine Tumorigenesis. Cancer Research. 67(9). 3998–4004. 62 indexed citations
16.
Peterson, Norman, Matthew D. Servinsky, Zhongsheng Peng, et al.. (2005). Tamoxifen resistance and Her2/neu expression in an aged, irradiated rat breast carcinoma model. Carcinogenesis. 26(9). 1542–1552. 13 indexed citations
17.
Samuels, Yardena, Luis A. Díaz, Oleg Schmidt‐Kittler, et al.. (2005). Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell. 7(6). 561–573. 727 indexed citations breakdown →
18.
Huang, Ching-Tai, David L. Huso, Tianhong Wang, et al.. (2003). CD4+ T Cells Pass Through an Effector Phase During the Process of In Vivo Tolerance Induction. The Journal of Immunology. 170(8). 3945–3953. 59 indexed citations
19.
Dang, Long H., Chetan Bettegowda, David L. Huso, Kenneth W. Kinzler, & Bert Vogelstein. (2001). Combination bacteriolytic therapy for the treatment of experimental tumors. Proceedings of the National Academy of Sciences. 98(26). 15155–15160. 446 indexed citations
20.
Wang, Yanshu, David L. Huso, Hugh Cahill, David K. Ryugo, & Jeremy Nathans. (2001). Progressive Cerebellar, Auditory, and Esophageal Dysfunction Caused by Targeted Disruption of thefrizzled-4 Gene. Journal of Neuroscience. 21(13). 4761–4771. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026